Oncopeptides AB (publ) (STO:ONCO)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.570
-0.013 (-0.82%)
Aug 13, 2026, 5:29 PM CET

Oncopeptides AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
205.1582.26178.54173.41344.52362.19
Short-Term Investments
---0.030.352.11
Cash & Short-Term Investments
205.1582.26178.54173.44344.86364.3
Cash Growth
91.33%-53.93%2.94%-49.71%-5.33%-57.27%
Accounts Receivable
41.637.777.292.190.6711.87
Other Receivables
-8.676.2415.6816.2524.01
Receivables
41.6316.4313.5317.8716.9235.89
Inventory
9.578.244.372.43--
Prepaid Expenses
-5.346.195.431.717.42
Other Current Assets
-05.279.963.730.544.76
Total Current Assets
256.35117.72217.08202.9364.03412.37
Property, Plant & Equipment
15.5517.6827.1134.6320.4424.74
Other Intangible Assets
-----1.41
Other Long-Term Assets
---00.850.850.85
Total Assets
271.89135.4244.19238.38385.32439.38

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
13.150.718.1715.0328.2235.7
Accrued Expenses
-28.3215.1220.3817.2436.61
Current Portion of Leases
-7.727.275.13610.99
Current Income Taxes Payable
-1.151.730.580.30.05
Current Unearned Revenue
-0.230.070.5--
Other Current Liabilities
43.156.934.663.3233.91141.94
Total Current Liabilities
56.3145.0651.3644.9385.67225.29
Long-Term Debt
130.8126.68121.89106.49--
Long-Term Leases
84.9812.5519.67-3.21
Other Long-Term Liabilities
-017.564.1110.515.360.01
Total Liabilities
195.11194.29189.91181.691.03228.51

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
43.8230.323.9110.5110.488.37
Additional Paid-In Capital
-5,8145,6845,4145,4034,982
Retained Earnings
--5,900-5,651-5,366-5,116-4,778
Comprehensive Income & Other
32.96-3.21-2.84-2.2-2.3-0.92
Shareholders' Equity
76.79-58.8954.2956.78294.29210.87
Total Liabilities & Equity
271.89135.4244.19238.38385.32439.38

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
138.8139.39141.72131.29614.19
Net Cash (Debt)
66.35-57.1336.8242.15338.86350.11
Net Cash Growth
---12.65%-87.56%-3.21%-57.98%
Net Cash Per Share
0.27-0.250.220.474.124.65
Filing Date Shares Outstanding
395.29272.71215.1994.694.3175.29
Total Common Shares Outstanding
395.29272.71215.1994.694.3175.29
Working Capital
200.0472.66165.73157.97278.36187.08
Book Value Per Share
0.19-0.220.250.603.122.80
Tangible Book Value
76.79-58.8954.2956.78294.29209.46
Tangible Book Value Per Share
0.19-0.220.250.603.122.78
Machinery
-16.4616.4616.115.9914.42